Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Some of the patients affected by Out-of-hospital cardiac arrest (OHCA) with ventricular fibrillation (VF)/ventricular tachycardia (VT) do not respond to initial defibrillation. The survival decreases with number of defibrillations required to terminate VF/VT. In 2022, one prospective cluster randomized trial showed increased survival among (OHCA) patients in refractory VF using Double Sequential Defibrillation (DSD).
To evaluate feasibility and safety this randomized pilot trial will compare the effect of double defibrillation strategy initiated as soon as possible after the first defibrillation with continued resuscitation using standard defibrillation, in patients with Out of Hospital Cardiac arrest (OHCA). The results from this pilot trial will form the basis for design of a larger multicenter survival study.
The Dubbel-D study is an academic, investigator initiated, open-label pilot study with a randomized controlled trial (RCT) design conducted in the prehospital emergency medical services, i.e. ambulance organizations. The trial will be conducted by participating ambulance units attending OHCA´s. These units will perform screening for inclusion, randomization, intervention or control treatment and initial follow-up.
In all cases of OHCA a defibrillator should always be attached with the standard pad placement, anterio-lateral (A-L) position first. This is in accordance with standard of care. If there is VT/VF or an automated external defibrillator (AED) suggests defibrillation, defibrillation should be performed, and immediate chest compressions resumed. Thereafter, the patient can be screened for inclusion. If two study specific defibrillators (Corpulse 3) on site and no exclusion criteria (age below 18 years, obvious pregnancy, known preexisting Do Not Attempt Resuscitation order) the patient can be included and randomized.
Randomization will be performed by drawing a scratch-card with concealed allocation that will be stored with the EMS defibrillators. All scratch-cards will be pre-randomized in a 3:1 ratio in blocks consisting of 4-8-12 and stratified by region and ambulance provider.
If the patient is randomized to the intervention group, the ambulance crew team will apply the second defibrillator with electrodes placed in the anterio-posterior (A-P) position as soon as possible. Defibrillation is performed by one person defibrillating both defibrillators in a sequential manner "Double Sequential Defibrillation" (DSD). All consecutive defibrillations will thereafter be performed with the DSD strategy until ROSC, termination of resuscitation or decision to move the patient to hospital.
If randomized to the control group, the ambulance crew team will continue Advanced Life Support (ACLS) in accordance with standard of care. Defibrillation is performed with standard electrode placement (A-L position) using a single defibrillator. If an AED is the first defibrillator attached to the patient, the ambulance crew should shift from an AED to their own manual defibrillator, but the mode of defibrillation should remain in A-L position and only one defibrillator should be used for each defibrillation and continue until ROSC, termination of resuscitation or decision to move the patient to hospital.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Double Sequential Defibrillation (DSD) | Experimental | If the patient is randomized to the DSD group, the ambulance crew team will apply the second defibrillator with electrodes placed in the A-P position as soon as possible. Defibrillation is performed by one person defibrillating both defibrillators in a sequential manner "Double Sequential Defibrillation" (DSD). All consecutive defibrillations will thereafter be performed with the DSD strategy until ROSC, termination of resuscitation or decision to move the patient to hospital. |
|
| Standard defibrillation | Active Comparator | If the patient is randomized to the standard defibrillation group, the ambulance crew team will continue Advanced life support in accordance with standard of care and continue to perform standard defibibrillation using one defibrillator. All consecutive defibrillations will thereafter be performed with the standard defibrillation strategy until ROSC, termination of resuscitation or decision to move the patient to hospital. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Double Sequential Defibrillation (DSD) | Device | The second defibrillator will be applyed with electrodes placed in the A-P position |
|
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of early double sequential external defibrillation (DSD) | Number of EMS defibrillations prior to randomization (target > 80% before third defibrillation) | day 1 |
| Adherence to double sequential external defibrillation (DSD) | Among patients randomized to DSD, proportion that received DSD (target > 80%) | day 1 |
| Cross-over | Among patients randomized to standard, proportion that received DSD (target < 10%) | day 1 |
| Feasibility of double sequential external defibrillation (DSD) | Proportion of eligible patients included and randomized (target > 80%) | day 1 |
| Safety of double sequential external defibrillation | Major adverse events (e.g. defibrillator malfunction) | day 1 |
| Safety of CPR during double sequential external defibrillation | Chest compression fraction (hands off time during CPR, target > 80% in both groups) | day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Return of spontaneous circulation (ROSC) | Proportion of patients with sustained return of spontaneous circulation (ROSC) at hospital arrival | day 1 |
| Number of defibrillations to sustained ROSC |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gabriel Riva, MD, PhD | Karolinska Institutet | Principal Investigator |
| Akil Awad, MD, PhD | Karolinska Institutet | Principal Investigator |
| Andreas Claesson, RN, PhD | Karolinska Institutet | Study Chair |
| Carl Magnusson, RN, PhD | Sahlgrenska University | Study Chair |
| Leif Svensson, MD, PhD | Karolinska Institutet | Study Chair |
| Johan Israelsson, RN, PhD | Linné University | Study Chair |
| Emma Blick-Nordqvist, MD | Karolinska Institutet | Study Chair |
| Martin Jonsson, Msc, PhD | Karolinska Institutet | Study Chair |
| Jacob Hollenberg, MD, PhD | Karolinska Institutet | Study Chair |
| Sheldon Cheskes, MD | University of Toronto |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Emergency medical services Region Halland | Halmstad | Halland County | 30238 | Sweden | ||
| Sahlgrenska Universitetssjukhuset, Ambulans och Prehospital Akutsjukvård |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36342151 | Result | Cheskes S, Verbeek PR, Drennan IR, McLeod SL, Turner L, Pinto R, Feldman M, Davis M, Vaillancourt C, Morrison LJ, Dorian P, Scales DC. Defibrillation Strategies for Refractory Ventricular Fibrillation. N Engl J Med. 2022 Nov 24;387(21):1947-1956. doi: 10.1056/NEJMoa2207304. Epub 2022 Nov 6. | |
| 42379878 | Derived |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Sep 23, 2024 | Dec 11, 2024 | Prot_001.pdf |
Not provided
| ID | Term |
|---|---|
| D006323 | Heart Arrest |
| D014693 | Ventricular Fibrillation |
| D016757 | Death, Sudden, Cardiac |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001145 | Arrhythmias, Cardiac |
| D010335 | Pathologic Processes |
Not provided
Not provided
Academic, investigator initiated, open-label pilot study with a randomized controlled trial (RCT) design and 3:1 allocation (3 intervention: 1 standard).
Not provided
Not provided
Not provided
| Standard defibrillation | Device | Standard defibrillation uning one defibrillator |
|
Total number of defibrillations to sustained ROSC
| day 1 |
| Survival to hospital admission | Pateint is admitted to hospital alive | day 1 |
| Survival to discharge | Survival to hospital discharge | day 1-180 |
| 30 day survival | Survival at 30 days | day 30 |
| Neurological function at 30 days | Neurological function (modified Rankin Scale, mRS 1-6, and Cerebral Performance Category, CPC 1-5) at 30 days | day 30 |
| Neurological function and Health related Quality of life at 90 and 180 days | Neurological function (modifiied Rankin Scale and Cerebral Performance Category) and Health-related Quality of life at 90 and 180 days (CPC 1-5, mRS 1-6) | day 90 and 180 |
| Study Chair |
| Gothenburg |
| Västra Götalandsregionen |
| 411 04 |
| Sweden |
| Sjukhusen i väster, ambulanssjukvården Alingsås/Lerum | Alingsås | Västra Götalandsregionen | 441 39 | Sweden |
| Riva G, Nordkvist EB, Magnusson C, Claesson A, Jonsson M, Israelsson J, Nordius C, Barret K, Sidebottom DB, Martner P, Cavefors O, Tenning A, Wibring K, Waldemar A, Edholm G, Awad A. Feasibility of early double sequential defibrillation in out-of-hospital cardiac arrest: the double-D randomised pilot trial. Heart. 2026 Jun 30:heartjnl-2026-327905. doi: 10.1136/heartjnl-2026-327905. Online ahead of print. |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D003645 | Death, Sudden |
| D003643 | Death |